Q Med Abseminariegatan 21uppsala Se 75 752 Pma Numberp040024 Supplement Numbers134 Date Received09 07 2022 Decision Date09 30 2022 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Q Med Abseminariegatan 21uppsala Se 75 752 Pma Numberp040024 Supplement Numbers134 Date Received09 07 2022 Decision Date09 30 2022 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P040024S134 Q-Med ABseminariegatan 21uppsala SE-75-752- PMA NumberP040024 Supplement NumberS134 Date Received09/07/2022 Decision Date09/30/2022 Product Code LMH  Advisory Committee General & Plastic Surgery Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No	RESTYLANE® Injectable Gels	2022-09-30